| Overview |
| bsm-54144r-pe-cy5-100ul |
| OPA1 (9A7) Monoclonal Antibody, PE-Cy5 Conjugated |
| WB |
| Human, Mouse, Rat |
| Specifications |
| PE-Cy5 |
| Rabbit |
| C terminal Human OPA1 |
| Monoclonal |
| 9A7 |
| IgG |
| Lot Dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 4976 |
| O60313 |
| Mitochondrion |
| Dynamin-like 120 kDa protein mitochondrial; Optic atrophy protein 1; OPA1; KIAA0567. |
| OPA1 is a cause of optic atrophy type 1. OPA1 is mostly expressed in the mitochondrial biogenesis. OPA1 is a cause of optic atrophy type 1. OPA1 is mostly expressed In retina but can also be expressed in brain, testis, heart and skeletal muscles. This dynamin-related GTPase that is essential for normal mitochondrial morphology by regulating the equilibrium between mitochondrial fusion and mitochondrial fission. |
| Application Dilution |
| WB |
1:500-2000 |
Powered by Bioz